1Mero, N, Syvanne, M & Taskinen, MR (1998) Postprandial lipid metabolism in diabetes. Atherosclerosis 141, Suppl. 1, S53–S55.
2Karpe, F (1999) Postprandial lipoprotein metabolism and atherosclerosis. J Intern Med 246, 341–355.
3Krauss, RM (1998) Atherogenicity of triglyceride-rich lipoproteins. Am J Cardiol 81, 13B–17B.
4Eckel, RH, Grundy, SM & Zimmet, PZ (2005) The metabolic syndrome. Lancet 365, 1415–1428.
5Shepherd, J, Betteridge, J & Van Gaal, L (2005) Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel. Curr Med Res Opin 21, 665–682.
6Al-Delaimy, WK, Rimm, EB, Willett, WC, et al. (2004) Magnesium intake and risk of coronary heart disease among men. J Am Coll Nutr 23, 63–70.
7Abbott, RD, Ando, F, Masaki, KH, et al. (2003) Dietary magnesium intake and the future risk of coronary heart disease (The Honolulu Heart Program). Am J Cardiol 92, 665–669.
8Peterson, DR, Thompson, DJ & Nam, JM (1970) Water hardness, arteriosclerotic heart disease and sudden death. Am J Epidemiol 92, 90–93.
9Colditz, GA, Manson, JE, Stampfer, MJ, et al. (1992) Diet and risk of clinical diabetes in women. Am J Clin Nutr 55, 1018–1023.
10Song, Y, Manson, JE, Buring, JE, et al. (2004) Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes Care 27, 59–65.
11Ascherio, A, Hennekens, C, Willett, WC, et al. (1996) Prospective study of nutritional factors, blood pressure, and hypertension among US women. Hypertension 27, 1065–1072.
12Ascherio, A, Rimm, EB, Giovannucci, EL, et al. (1992) A prospective study of nutritional factors and hypertension among US men. Circulation 86, 1475–1484.
13Yokota, K, Kato, M, Lister, F, et al. (2004) Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr 23, 506S–509S.
14Unno, T, Tago, M, Suzuki, Y, et al. (2005) Effect of tea catechins on postprandial plasma lipid responses in human subjects. Br J Nutr 93, 543–547.
15Bhattacharyya, AK, Thera, C, Anderson, JT, et al. (1969) Dietary calcium and fat. Effect on serum lipids and fecal excretion of cholesterol and its degradation products in man. Am J Clin Nutr 22, 1161–1174.
16Gacs, G & Barltrop, D (1977) Significance of Ca-soap formation for calcium absorption in the rat. Gut 18, 64–68.
17Renaud, S, Ciavatti, M, Thevenon, C, et al. (1983) Protective effects of dietary calcium and magnesium on platelet function and atherosclerosis in rabbits fed saturated fat. Atherosclerosis 47, 187–198.
18Yacowitz, H, Fleischman, AI & Bierenbaum, ML (1965) Effects of oral calcium upon serum lipids in man. Br Med J 1, 1352–1354.
19Denke, MA, Fox, MM & Schulte, MC (1993) Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 123, 1047–1053.
20Rayssiguier, Y & Gueux, E (1986) Magnesium and lipids in cardiovascular disease. J Am Coll Nutr 5, 507–519.
21Proctor, SD & Mamo, JC (1996) Arterial fatty lesions have increased uptake of chylomicron remnants but not low-density lipoproteins. Coron Artery Dis 7, 239–245.
22Proctor, SD & Mamo, JC (1998) Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall-evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Eur J Clin Invest 28, 497–503.
23Bradley, WA & Gianturco, SH (1994) Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological considerations. J Intern Med Suppl 736, 33–39.
24Altura, BT, Brust, M, Bloom, S, et al. (1990) Magnesium dietary intake modulates blood lipid levels and atherogenesis. Proc Natl Acad Sci U S A 87, 1840–1844.
25Ravn, HB, Korsholm, TL & Falk, E (2001) Oral magnesium supplementation induces favorable antiatherogenic changes in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 21, 858–862.